Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
| Title: | Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial |
|---|---|
| Authors: | Algazi, Alain P.Aff1, IDs4159102010608_cor1; Othus, MeganAff2; Daud, Adil I.Aff1; Lo, Roger S.Aff3; Mehnert, Janice M.Aff4; Truong, Thach-GiaoAff5; Conry, RobertAff6; Kendra, KariAff7; Doolittle, Gary C.Aff8; Clark, Joseph I.Aff9; Messino, Michael J.Aff10; Moore, Dennis F.Aff11; Lao, ChristopherAff12; Faller, Bryan A.Aff13; Govindarajan, RangaswamyAff14; Harker-Murray, AmyAff15; Dreisbach, LukeAff16; Moon, JamesAff2; Grossmann, Kenneth F.Aff17; Ribas, AntoniAff3 |
| Source: | Nature Medicine. 26(10):1564-1568 |
| Database: | Springer Nature Journals |